The association of PARP1 and PARP2 expression with MSI in this study explains the association of PARPi response with low LST, rather than high LST, and this demonstrates why low LST, rather than high LST, would be the predictive biomarker of PARPi response in CRC. The gene discussed is PARP2; the disease is colorectal carcinoma.